145022-92-0

Tauro-β-muricholic acid (TβMCA) is a competitive and reversible antagonist of the farnesoid X receptor (FXR; IC₅₀ = 40 μM) and a taurine-conjugated form of the murine-specific primary bile acid β-muricholic acid . TβMCA accumulates in germ-free mice under normal conditions but is reduced after colonization with feces from a human donor. TβMCA is increased in the intestines of mice resistant to high-fat diet-induced obesity, fatty liver, and diabetes.

Tauro-β-muricholic Acid Sodium Salt is the salt form of Tauro-α-muricholic Acid which is a bile acid released by the liver and is typically used in cholestasis studies.

Store at -20°C

[1] SAMA I SAYIN. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.[J]. Cell metabolism, 2013, 17 2: 225-235. DOI: 10.1016/j.cmet.2013.01.003
[2] A. WAHLSTR?M. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota[S][J]. Journal of Lipid Research, 2017, 58 1: 412-419. DOI: 10.1194/jlr.m072819
[3] YUNPENG QI . Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice[J]. Biochimica et biophysica acta. Molecular and cell biology of lipids, 2015, 1851 1: Pages 19-29. DOI: 10.1016/j.bbalip.2014.04.008